BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Zona Fasciculata

Below is an extended Zona Fasciculata patents listing. Click here to return to the Zona Fasciculata main in depth entry.

Patents :

US Patent No.Title
5098944 Thermooxidative stabilization of polymers with a N4-alkylated oxo-piperazinyl-triazine
5624896 Clearing agents useful in pretargeting methods
5683997 Substituted benzazepinones
5703220 Genes encoding melanocertin-4 receptor and methods of use
5710265 Gene encoding melanocortin-5 receptor and methods of use
5773229 Mammalian adrenocorticotropic hormone receptors and uses
5792657 Steroid secreting human adrenocortical carcinoma cell lines
5817787 Probes and methods for detecting melanocortin-5 receptor
5847121 Production of nitro-benzyl-dota via direct peptide cyclization
5853765 Anti-cholesterolemic egg, vaccine and method for production, and use
5869257 Probes and methods for detecting melanocortin-4 receptor
5622860 Genes encoding melanocortin receptors
5616690 Hexose derivatized human serum albumin clearing agents
5610153 Benzazepinone derivatives
5223400 Immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
5236934 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
5280112 DNA sequence encoding bovine and human adrenocorticotropic hormone receptors
5362744 Tetrazole-substituted urea acat inhibitors
5420339 Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors
5502198 .alpha.-aryl or heteroaryl-substituted amide ester ACAT inhibitors
5503981 Isolation of fetal cells from maternal blood to enable prenatal diagnosis
5541287 Pretargeting methods and compounds
5554729 Mammalian adrenocorticotropic hormone receptors and uses
5578287 Three-step pretargeting methods using improved biotin-active agent
5932250 Anti-cholesterolemic egg, vaccine and method for production, and use
5976535 Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
6383766 Reduced cortisol conjugates
6392027 Mammalian adrenocorticotropic hormone receptor nucleic acids
6416738 Pretargeting methods and compounds
6903183 Compositions and methods for regulation of steroidogenesis
6967194 Bio-identical hormones and method of use
7029857 Processes for obtaining compounds employing SNORF72 receptors
7056694 DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use
7091248 Treatment of adrenocortical hypersecretion and tumor growth
7354608 Bio-identical hormones and method of use
7402730 Knockout animals manifesting hyperlipidemia
6380171 Pro-protein converting enzyme
6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
6358706 DNA encoding human alpha1G-C T-Type calcium channel
6015897 Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
6022966 Pretargeting methods and compounds
6046011 Mammalian adrenocorticotropic hormone receptors and uses
6075010 Small molecular weight ligand-hexose containing clearing agents
6117975 Melanocortin receptor polypeptides MC-3, MC-4, and MC-5
6147275 Corticotropin releasing factor receptor 1-deficient mice
6194555 Compositions and methods for regulation of steroidogenesis
6217869 Pretargeting methods and compounds
6353152 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
6358490 Three-step pretargeting methods and compounds
7407763 Systems and methods for detecting and regulating metastasis

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.